Prevalence of and risk factor for community-onset third-generation cephalosporin-resistant Escherichia coli bacteremia at a medical center in Taiwan

• Published in: BMC infectious diseases Vol. 19; no. 1; p. 245
• Main Authors: Lin, Wu-Pu, Huang, Yu-Shan, Wang, Jann-Tay, Chen, Yee-Chun, Chang, Shan-Chwen
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 12.03.2019; BioMed Central; BMC
• Subjects: Analysis; Antibiotics; Antimicrobial agents; Antimicrobial resistance; Appropriate empirical treatment; Bacteremia; Bacteria; Care and treatment; Cephalosporins; Community-onset infection; Confidence intervals; Drug resistance; E coli; Emergency medical care; Empirical analysis; Escherichia coli; Escherichia coli infections; Health care facilities; Health care industry; Health facilities; Health risks; Health services; Immunology; Impact resistance; Infection; Infections; Infectious diseases; Intravenous administration; Long term care; Long term health care; Medical centers; Microbial drug resistance; Mortality; Older people; Outpatient care facilities; Pathogenic microorganisms; Pathogens; Patients; Prevalence studies (Epidemiology); Prostheses and implants; Resistance factors; Risk analysis; Risk factors; Teachers; Teaching hospitals; Third-generation cephalosporin resistance; Taiwan; Appropriate empirical treatment; Community-onset infection; Third-generation cephalosporin resistance; Escherichia coli; Bacteremia

Increased resistance to third-generation cephalosporin (3GC) is a serious concern for community-onset Escherichia coli infection because this resistance easily delays effective treatment. This study surveyed the current antimicrobial resistance pattern among E. coli isolates that cause community-ons...